{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T19:46:56Z","timestamp":1789588016525,"version":"build-2803163510"},"reference-count":148,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100006407","name":"Natural Science Foundation of Henan Province","doi-asserted-by":"publisher","award":["212300410398"],"award-info":[{"award-number":["212300410398"]}],"id":[{"id":"10.13039\/501100006407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013072","name":"Major Science and Technology Project of Hainan Province","doi-asserted-by":"publisher","award":["221100310100"],"award-info":[{"award-number":["221100310100"]}],"id":[{"id":"10.13039\/501100013072","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.intimp.2024.113147","type":"journal-article","created":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T14:08:10Z","timestamp":1726150090000},"page":"113147","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"PA","title":["Proteogenomics offers a novel avenue in neoantigen identification for cancer immunotherapy"],"prefix":"10.1016","volume":"142","author":[{"given":"Yuqing","family":"Ren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyuan","family":"Weng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tengfei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaoqu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinwei","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.intimp.2024.113147_b0005","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s12943-019-1055-6","article-title":"Neoantigen vaccine: an emerging tumor immunotherapy","volume":"18","author":"Peng","year":"2019","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.intimp.2024.113147_b0010","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.836821","article-title":"Cancer Neoantigens: Challenges and Future Directions for Prediction, Prioritization, and Validation","volume":"12","author":"Borden","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.intimp.2024.113147_b0015","doi-asserted-by":"crossref","first-page":"4325874","DOI":"10.1155\/2018\/4325874","article-title":"Recent Development and Clinical Application of Cancer Vaccine: Targeting Neoantigens","volume":"2018","author":"Pan","year":"2018","journal-title":"J. Immunol. Res."},{"issue":"11\u201312","key":"10.1016\/j.intimp.2024.113147_b0020","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1080\/14789450.2020.1881889","article-title":"A proteogenomic approach to target neoantigens in solid tumors","volume":"17","author":"Verma","year":"2020","journal-title":"Expert Rev. Proteomics"},{"issue":"5","key":"10.1016\/j.intimp.2024.113147_b0025","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/s43018-021-00210-y","article-title":"Targeting public neoantigens for cancer immunotherapy","volume":"2","author":"Pearlman","year":"2021","journal-title":"Nat Cancer"},{"issue":"9","key":"10.1016\/j.intimp.2024.113147_b0030","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/pin.12841","article-title":"Proteogenomic discovery of cancer antigens: Neoantigens and beyond","volume":"69","author":"Kanaseki","year":"2019","journal-title":"Pathol. Int."},{"issue":"2","key":"10.1016\/j.intimp.2024.113147_b0035","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1093\/bib\/bbw114","article-title":"Genome, transcriptome and proteome: the rise of omics data and their integration in biomedical sciences","volume":"19","author":"Manzoni","year":"2018","journal-title":"Brief. Bioinform."},{"issue":"2","key":"10.1016\/j.intimp.2024.113147_b0040","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/cas.13131","article-title":"Prediction and prioritization of neoantigens: integration of RNA sequencing data with whole-exome sequencing","volume":"108","author":"Karasaki","year":"2017","journal-title":"Cancer Sci."},{"issue":"1","key":"10.1016\/j.intimp.2024.113147_b0045","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s00005-019-00566-1","article-title":"HER2-Positive Breast Cancer Immunotherapy: A Focus on Vaccine Development","volume":"68","author":"Arab","year":"2020","journal-title":"Arch. Immunol. Ther. Exp. (warsz)"},{"key":"10.1016\/j.intimp.2024.113147_b0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-230X(06)95001-5","article-title":"NY-ESO-1: review of an immunogenic tumor antigen","volume":"95","author":"Gnjatic","year":"2006","journal-title":"Adv. Cancer Res."},{"issue":"8","key":"10.1016\/j.intimp.2024.113147_b0055","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/nrc1669","article-title":"Cancer\/testis antigens, gametogenesis and cancer","volume":"5","author":"Simpson","year":"2005","journal-title":"Nat. Rev. Cancer"},{"issue":"2","key":"10.1016\/j.intimp.2024.113147_b0060","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1006\/gyno.1994.1033","article-title":"Detection of human papillomavirus type 16 E6\/E7 transcripts in histologically cancer-free pelvic lymph nodes of patients with cervical carcinoma","volume":"52","author":"Rose","year":"1994","journal-title":"Gynecol. Oncol."},{"issue":"9","key":"10.1016\/j.intimp.2024.113147_b0065","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/nrc.2017.74","article-title":"Targeting neoantigens to augment antitumour immunity","volume":"17","author":"Yarchoan","year":"2017","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.intimp.2024.113147_b0070","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/cas.12830","article-title":"Immune responses to human cancer stem-like cells\/cancer-initiating cells","volume":"107","author":"Hirohashi","year":"2016","journal-title":"Cancer Sci."},{"issue":"4","key":"10.1016\/j.intimp.2024.113147_b0075","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.immuni.2021.03.001","article-title":"Atypical acute myeloid leukemia-specific transcripts generate shared and immunogenic MHC class-I-associated epitopes","volume":"54","author":"Ehx","year":"2021","journal-title":"Immunity"},{"issue":"7","key":"10.1016\/j.intimp.2024.113147_b0080","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/S1470-2045(18)30254-7","article-title":"MAGE-A3 immunotherapeutic as adjuvant therapy for patients with resected, MAGE-A3-positive, stage III melanoma (DERMA): a double-blind, randomised, placebo-controlled, phase 3 trial","volume":"19","author":"Dreno","year":"2018","journal-title":"Lancet Oncol."},{"issue":"6","key":"10.1016\/j.intimp.2024.113147_b0085","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/S1470-2045(16)00099-1","article-title":"Efficacy of the MAGE-A3 cancer immunotherapeutic as adjuvant therapy in patients with resected MAGE-A3-positive non-small-cell lung cancer (MAGRIT): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"17","author":"Vansteenkiste","year":"2016","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.intimp.2024.113147_b0090","doi-asserted-by":"crossref","unstructured":"Alsalloum, A., J.A. Shevchenko, and S. Sennikov, The Melanoma-Associated Antigen Family A (MAGE-A): A Promising Target for Cancer Immunotherapy? Cancers (Basel), 2023. 15(6).","DOI":"10.3390\/cancers15061779"},{"issue":"2","key":"10.1016\/j.intimp.2024.113147_b0095","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/CJI.0b013e3182829903","article-title":"Cancer regression and neurological toxicity following anti-MAGE-A3 TCR gene therapy","volume":"36","author":"Morgan","year":"2013","journal-title":"J. Immunother."},{"issue":"1","key":"10.1016\/j.intimp.2024.113147_b0100","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/cr.2016.153","article-title":"Immunotherapy against cancer-related viruses","volume":"27","author":"Tashiro","year":"2017","journal-title":"Cell Res."},{"key":"10.1016\/j.intimp.2024.113147_b0105","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.701777","article-title":"Personalized Neoantigen-Pulsed DC Vaccines: Advances in Clinical Applications","volume":"11","author":"Tang","year":"2021","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.intimp.2024.113147_b0110","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s40364-021-00315-7","article-title":"Targeting neoantigens for cancer immunotherapy","volume":"9","author":"Zhao","year":"2021","journal-title":"Biomark Res"},{"key":"10.1016\/j.intimp.2024.113147_b0115","doi-asserted-by":"crossref","unstructured":"Chong, C., et al., Integrated proteogenomic deep sequencing and analytics accurately identify non-canonical peptides in tumor immunopeptidomes. Nature Communications, 2020. 11(1).","DOI":"10.1038\/s41467-020-14968-9"},{"key":"10.1016\/j.intimp.2024.113147_b0120","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.583287","article-title":"A Roadmap Toward the Definition of Actionable Tumor-Specific Antigens","volume":"11","author":"Minati","year":"2020","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.intimp.2024.113147_b0125","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/s41568-019-0162-4","article-title":"Alternative tumour-specific antigens","volume":"19","author":"Smith","year":"2019","journal-title":"Nat. Rev. Cancer"},{"issue":"3","key":"10.1016\/j.intimp.2024.113147_b0130","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/nri.2018.3","article-title":"The tumour glyco-code as a novel immune checkpoint for immunotherapy","volume":"18","author":"Rodr\u00cdguez","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.intimp.2024.113147_b0135","first-page":"2","volume":"9","author":"Zhao","year":"2021","journal-title":"Cancer Vaccines: Antigen Selection Strategy. Vaccines (basel)"},{"issue":"7","key":"10.1016\/j.intimp.2024.113147_b0140","doi-asserted-by":"crossref","first-page":"550","DOI":"10.7326\/0003-4819-138-7-200304010-00011","article-title":"Gene vaccines","volume":"138","author":"Srivastava","year":"2003","journal-title":"Ann. Intern. Med."},{"issue":"2","key":"10.1016\/j.intimp.2024.113147_b0145","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1039\/C5SC03892H","article-title":"Peptide-based synthetic vaccines","volume":"7","author":"Skwarczynski","year":"2016","journal-title":"Chem. Sci."},{"issue":"7","key":"10.1016\/j.intimp.2024.113147_b0150","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1007\/s00262-023-03409-3","article-title":"Alanine-based spacers promote an efficient antigen processing and presentation in neoantigen polypeptide vaccines","volume":"72","author":"Aguilar-Gurrieri","year":"2023","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.intimp.2024.113147_b0155","doi-asserted-by":"crossref","unstructured":"Kumari, K., et al., Neoantigen Identification and Dendritic Cell-Based Vaccines for Lung Cancer Immunotherapy. Vaccines (Basel), 2024. 12(5).","DOI":"10.3390\/vaccines12050498"},{"issue":"1","key":"10.1016\/j.intimp.2024.113147_b0160","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41392-022-01270-x","article-title":"Neoantigens: promising targets for cancer therapy","volume":"8","author":"Xie","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"12","key":"10.1016\/j.intimp.2024.113147_b0165","doi-asserted-by":"crossref","first-page":"3579","DOI":"10.1016\/j.ymthe.2023.10.021","article-title":"Complete remission of tumors in mice with neoantigen-painted exosomes and anti-PD-1 therapy","volume":"31","author":"Zhang","year":"2023","journal-title":"Mol. Ther."},{"key":"10.1016\/j.intimp.2024.113147_b0170","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.jconrel.2022.11.053","article-title":"Dendritic cell derived exosomes loaded neoantigens for personalized cancer immunotherapies","volume":"353","author":"Li","year":"2023","journal-title":"J. Control. Release"},{"issue":"6","key":"10.1016\/j.intimp.2024.113147_b0175","doi-asserted-by":"crossref","first-page":"e12466","DOI":"10.1002\/jev2.12466","article-title":"Gut-liver axis: Potential mechanisms of action of food-derived extracellular vesicles","volume":"13","author":"Zhang","year":"2024","journal-title":"J Extracell Vesicles"},{"issue":"24","key":"10.1016\/j.intimp.2024.113147_b0180","doi-asserted-by":"crossref","first-page":"12472","DOI":"10.18632\/oncotarget.2998","article-title":"Classification of current anticancer immunotherapies","volume":"5","author":"Galluzzi","year":"2014","journal-title":"Oncotarget"},{"issue":"7","key":"10.1016\/j.intimp.2024.113147_b0185","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.4161\/hv.29604","article-title":"Active and passive immunization for cancer","volume":"10","author":"Baxter","year":"2014","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.intimp.2024.113147_b0190","doi-asserted-by":"crossref","first-page":"3264217","DOI":"10.1155\/2017\/3264217","article-title":"Advances in Immunotherapy for Melanoma: A Comprehensive Review","volume":"2017","author":"Rodriguez-Cerdeira","year":"2017","journal-title":"Mediators Inflamm."},{"issue":"6","key":"10.1016\/j.intimp.2024.113147_b0195","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1159\/000503254","article-title":"Scientific Rationale for Combination Immunotherapy of Hepatocellular Carcinoma with Anti-PD-1\/PD-L1 and Anti-CTLA-4 Antibodies","volume":"8","author":"Kudo","year":"2019","journal-title":"Liver Cancer"},{"issue":"2","key":"10.1016\/j.intimp.2024.113147_b0200","first-page":"182","article-title":"Immune Checkpoint Blockers and Ovarian Cancer","volume":"38","author":"Bose","year":"2017","journal-title":"Indian J Med Paediatr Oncol"},{"key":"10.1016\/j.intimp.2024.113147_b0205","doi-asserted-by":"crossref","unstructured":"Ivica, N.A. and C.M. Young, Tracking the CAR-T Revolution: Analysis of Clinical Trials of CAR-T and TCR-T Therapies for the Treatment of Cancer (1997-2020). Healthcare (Basel), 2021. 9(8).","DOI":"10.3390\/healthcare9081062"},{"issue":"1","key":"10.1016\/j.intimp.2024.113147_b0210","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.1038\/s41467-020-17670-y","article-title":"A decade of immune-checkpoint inhibitors in cancer therapy","volume":"11","author":"Robert","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2024.113147_b0215","article-title":"Neoantigen: A New Breakthrough in Tumor Immunotherapy","volume":"12","author":"Zhang","year":"2021","journal-title":"Front. Immunol."},{"issue":"7662","key":"10.1016\/j.intimp.2024.113147_b0220","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nature23003","article-title":"Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer","volume":"547","author":"Sahin","year":"2017","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.intimp.2024.113147_b0225","doi-asserted-by":"crossref","first-page":"5976","DOI":"10.1172\/JCI134915","article-title":"mRNA vaccine-induced neoantigen-specific T cell immunity in patients with gastrointestinal cancer","volume":"130","author":"Cafri","year":"2020","journal-title":"J Clin Invest"},{"key":"10.1016\/j.intimp.2024.113147_b0230","doi-asserted-by":"crossref","unstructured":"Carreno, B.M., et al., Cancer immunotherapy. A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells. Science, 2015. 348(6236): p. 803-8.","DOI":"10.1126\/science.aaa3828"},{"issue":"1","key":"10.1016\/j.intimp.2024.113147_b0235","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41392-020-00448-5","article-title":"Personalized neoantigen pulsed dendritic cell vaccine for advanced lung cancer","volume":"6","author":"Ding","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"issue":"7662","key":"10.1016\/j.intimp.2024.113147_b0240","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nature22991","article-title":"An immunogenic personal neoantigen vaccine for patients with melanoma","volume":"547","author":"Ott","year":"2017","journal-title":"Nature"},{"issue":"7745","key":"10.1016\/j.intimp.2024.113147_b0245","doi-asserted-by":"crossref","first-page":"E13","DOI":"10.1038\/s41586-019-0959-z","article-title":"Publisher Correction: Actively personalized vaccination trial for newly diagnosed glioblastoma","volume":"566","author":"Hilf","year":"2019","journal-title":"Nature"},{"issue":"7738","key":"10.1016\/j.intimp.2024.113147_b0250","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/s41586-018-0792-9","article-title":"Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial","volume":"565","author":"Keskin","year":"2019","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.intimp.2024.113147_b0255","doi-asserted-by":"crossref","first-page":"6325","DOI":"10.1172\/JCI140378","article-title":"Mass cytometry detects H3.3K27M-specific vaccine responses in diffuse midline glioma","volume":"130","author":"Mueller","year":"2020","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.intimp.2024.113147_b0260","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.cell.2020.08.053","article-title":"A Phase Ib Trial of Personalized Neoantigen Therapy Plus Anti-PD-1 in Patients with Advanced Melanoma, Non-small Cell Lung Cancer, or Bladder Cancer","volume":"183","author":"Ott","year":"2020","journal-title":"Cell"},{"issue":"7854","key":"10.1016\/j.intimp.2024.113147_b0265","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/s41586-021-03363-z","article-title":"A vaccine targeting mutant IDH1 in newly diagnosed glioma","volume":"592","author":"Platten","year":"2021","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.intimp.2024.113147_b0270","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.ccell.2022.08.003","article-title":"Personalized neoantigen vaccine NEO-PV-01 with chemotherapy and anti-PD-1 as first-line treatment for non-squamous non-small cell lung cancer","volume":"40","author":"Awad","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.intimp.2024.113147_b0275","doi-asserted-by":"crossref","first-page":"1000681","DOI":"10.3389\/fimmu.2022.1000681","article-title":"Combination treatment of radiofrequency ablation and peptide neoantigen vaccination: Promising modality for future cancer immunotherapy","volume":"13","author":"Shou","year":"2022","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.intimp.2024.113147_b0280","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1038\/s41591-022-01937-6","article-title":"Individualized, heterologous chimpanzee adenovirus and self-amplifying mRNA neoantigen vaccine for advanced metastatic solid tumors: phase 1 trial interim results","volume":"28","author":"Palmer","year":"2022","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.intimp.2024.113147_b0285","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/pmic.200300511","article-title":"Proteogenomic mapping as a complementary method to perform genome annotation","volume":"4","author":"Jaffe","year":"2004","journal-title":"Proteomics"},{"issue":"5","key":"10.1016\/j.intimp.2024.113147_b0290","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/s41568-022-00446-5","article-title":"Cancer proteogenomics: current impact and future prospects","volume":"22","author":"Mani","year":"2022","journal-title":"Nat Rev Cancer"},{"issue":"7518","key":"10.1016\/j.intimp.2024.113147_b0295","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/nature13438","article-title":"Proteogenomic characterization of human colon and rectal cancer","volume":"513","author":"Zhang","year":"2014","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.intimp.2024.113147_b0300","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.cell.2019.03.030","article-title":"Proteogenomic Analysis of Human Colon Cancer Reveals New Therapeutic Opportunities","volume":"177","author":"Vasaikar","year":"2019","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.intimp.2024.113147_b0305","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.ccell.2020.08.002","article-title":"Integrated Omics of Metastatic Colorectal Cancer","volume":"38","author":"Li","year":"2020","journal-title":"Cancer Cell"},{"issue":"3","key":"10.1016\/j.intimp.2024.113147_b0310","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.cell.2016.05.069","article-title":"Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer","volume":"166","author":"Zhang","year":"2016","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.intimp.2024.113147_b0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108276","article-title":"Integrated Proteomic and Glycoproteomic Characterization of Human High-Grade Serous Ovarian Carcinoma","volume":"33","author":"Hu","year":"2020","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.intimp.2024.113147_b0320","article-title":"Proteogenomic Characterization of Ovarian HGSC Implicates Mitotic Kinases, Replication Stress in Observed Chromosomal Instability","volume":"1","author":"McDermott","year":"2020","journal-title":"Cell Rep Med"},{"issue":"7605","key":"10.1016\/j.intimp.2024.113147_b0325","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nature18003","article-title":"Proteogenomics connects somatic mutations to signalling in breast cancer","volume":"534","author":"Mertins","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2024.113147_b0330","doi-asserted-by":"crossref","first-page":"14864","DOI":"10.1038\/ncomms14864","article-title":"Proteogenomic integration reveals therapeutic targets in breast cancer xenografts","volume":"8","author":"Huang","year":"2017","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.intimp.2024.113147_b0335","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1158\/0008-5472.CAN-17-1990","article-title":"Mass Spectrometry-Based Proteomics Reveals Potential Roles of NEK9 and MAP2K4 in Resistance to PI3K Inhibition in Triple-Negative Breast Cancers","volume":"78","author":"Mundt","year":"2018","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.intimp.2024.113147_b0340","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1038\/s41467-019-09018-y","article-title":"Breast cancer quantitative proteome and proteogenomic landscape","volume":"10","author":"Johansson","year":"2019","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.intimp.2024.113147_b0345","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/j.cell.2020.10.036","article-title":"Proteogenomic Landscape of Breast Cancer Tumorigenesis and Targeted Therapy","volume":"183","author":"Krug","year":"2020","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.intimp.2024.113147_b0350","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/s41467-020-14381-2","article-title":"Microscaled proteogenomic methods for precision oncology","volume":"11","author":"Satpathy","year":"2020","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.intimp.2024.113147_b0355","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.ccell.2018.08.004","article-title":"Proteomics, Post-translational Modifications, and Integrative Analyses Reveal Molecular Heterogeneity within Medulloblastoma Subgroups","volume":"34","author":"Archer","year":"2018","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.intimp.2024.113147_b0360","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s40478-018-0548-7","article-title":"Proteomic analysis of Medulloblastoma reveals functional biology with translational potential","volume":"6","author":"Rivero-Hinojosa","year":"2018","journal-title":"Acta Neuropathol. Commun."},{"issue":"7","key":"10.1016\/j.intimp.2024.113147_b0365","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1016\/j.cell.2020.10.044","article-title":"Integrated Proteogenomic Characterization across Major Histological Types of Pediatric Brain Cancer","volume":"183","author":"Petralia","year":"2020","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.intimp.2024.113147_b0370","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ccell.2021.01.006","article-title":"Proteogenomic and metabolomic characterization of human glioblastoma","volume":"39","author":"Wang","year":"2021","journal-title":"Cancer Cell"},{"issue":"9","key":"10.1016\/j.intimp.2024.113147_b0375","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.108787","article-title":"Proteogenomics of glioblastoma associates molecular patterns with survival","volume":"34","author":"Yanovich-Arad","year":"2021","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.intimp.2024.113147_b0380","doi-asserted-by":"crossref","first-page":"3578","DOI":"10.1038\/s41467-019-11452-x","article-title":"Proteogenomic landscape of squamous cell lung cancer","volume":"10","author":"Stewart","year":"2019","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.intimp.2024.113147_b0385","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.cell.2020.06.012","article-title":"Proteogenomics of Non-smoking Lung Cancer in East Asia Delineates Molecular Signatures of Pathogenesis and Progression","volume":"182","author":"Chen","year":"2020","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.intimp.2024.113147_b0390","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.cell.2020.06.013","article-title":"Proteogenomic Characterization Reveals Therapeutic Vulnerabilities in Lung Adenocarcinoma","volume":"182","author":"Gillette","year":"2020","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.intimp.2024.113147_b0395","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.cell.2020.05.043","article-title":"Integrative Proteomic Characterization of Human Lung Adenocarcinoma","volume":"182","author":"Xu","year":"2020","journal-title":"Cell"},{"issue":"16","key":"10.1016\/j.intimp.2024.113147_b0400","doi-asserted-by":"crossref","first-page":"4348","DOI":"10.1016\/j.cell.2021.07.016","article-title":"A proteogenomic portrait of lung squamous cell carcinoma","volume":"184","author":"Satpathy","year":"2021","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.intimp.2024.113147_b0405","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1038\/s41467-018-03573-6","article-title":"Integrative proteomics in prostate cancer uncovers robustness against genomic and transcriptomic aberrations during disease progression","volume":"9","author":"Latonen","year":"2018","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.intimp.2024.113147_b0410","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1158\/1078-0432.CCR-18-0729","article-title":"Proteogenomic Characterization of Patient-Derived Xenografts Highlights the Role of REST in Neuroendocrine Differentiation of Castration-Resistant Prostate Cancer","volume":"25","author":"Flores-Morales","year":"2019","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.intimp.2024.113147_b0415","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.ccell.2019.02.005","article-title":"The Proteogenomic Landscape of Curable Prostate Cancer","volume":"35","author":"Sinha","year":"2019","journal-title":"Cancer Cell"},{"issue":"5","key":"10.1016\/j.intimp.2024.113147_b0420","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/j.cell.2019.10.038","article-title":"Integrated Proteogenomic Characterization of HBV-Related Hepatocellular Carcinoma","volume":"179","author":"Gao","year":"2019","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.intimp.2024.113147_b0425","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.cell.2019.10.007","article-title":"Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma","volume":"179","author":"Clark","year":"2019","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.intimp.2024.113147_b0430","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ccell.2018.12.003","article-title":"Proteogenomic Characterization of Human Early-Onset Gastric Cancer","volume":"35","author":"Mun","year":"2019","journal-title":"Cancer Cell"},{"issue":"4","key":"10.1016\/j.intimp.2024.113147_b0435","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.cell.2020.01.026","article-title":"Proteogenomic Characterization of Endometrial Carcinoma","volume":"180","author":"Dou","year":"2020","journal-title":"Cell"},{"issue":"19","key":"10.1016\/j.intimp.2024.113147_b0440","doi-asserted-by":"crossref","first-page":"5031","DOI":"10.1016\/j.cell.2021.08.023","article-title":"Proteogenomic characterization of pancreatic ductal adenocarcinoma","volume":"184","author":"Cao","year":"2021","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.intimp.2024.113147_b0445","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/nrg.2016.67","article-title":"Computational genomics tools for dissecting tumour-immune cell interactions","volume":"17","author":"Hackl","year":"2016","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.intimp.2024.113147_b0450","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.csbj.2016.07.002","article-title":"Well-characterized sequence features of eukaryote genomes and implications for ab initio gene prediction","volume":"14","author":"Huang","year":"2016","journal-title":"Comput. Struct. Biotechnol. J."},{"issue":"5","key":"10.1016\/j.intimp.2024.113147_b0455","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/j.celrep.2013.10.041","article-title":"Quantitative and qualitative proteome characteristics extracted from in-depth integrated genomics and proteomics analysis","volume":"5","author":"Low","year":"2013","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.intimp.2024.113147_b0460","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12863-017-0479-5","article-title":"Opportunities and challenges of whole-genome and -exome sequencing","volume":"18","author":"Petersen","year":"2017","journal-title":"BMC Genet."},{"issue":"2","key":"10.1016\/j.intimp.2024.113147_b0465","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/nrg2934","article-title":"RNA sequencing: advances, challenges and opportunities","volume":"12","author":"Ozsolak","year":"2011","journal-title":"Nat. Rev. Genet."},{"issue":"5","key":"10.1016\/j.intimp.2024.113147_b0470","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17050632","article-title":"Advantages and Pitfalls of Mass Spectrometry Based Metabolome Profiling in Systems Biology","volume":"17","author":"Aretz","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2024.113147_b0475","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.freeradbiomed.2013.08.184","article-title":"Post-translational modifications and mass spectrometry detection","volume":"65","author":"Silva","year":"2013","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.intimp.2024.113147_b0480","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.cca.2019.08.010","article-title":"Proteogenomics: From next-generation sequencing (NGS) and mass spectrometry-based proteomics to precision medicine","volume":"498","author":"Ang","year":"2019","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.intimp.2024.113147_b0485","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109542","article-title":"Application of mass spectrometry-based MHC immunopeptidome profiling in neoantigen identification for tumor immunotherapy","volume":"120","author":"Zhang","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.intimp.2024.113147_b0490","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodchem.2021.130450","article-title":"Data-dependent acquisition based high-resolution mass spectrum for trace Alternaria mycotoxin analysis and sulfated metabolites identification","volume":"364","author":"Zhang","year":"2021","journal-title":"Food Chem."},{"issue":"15","key":"10.1016\/j.intimp.2024.113147_b0495","doi-asserted-by":"crossref","first-page":"10830","DOI":"10.1021\/acs.analchem.0c02313","article-title":"Combinatory Data-Independent Acquisition and Parallel Reaction Monitoring Method for Deep Profiling of Gangliosides","volume":"92","author":"Li","year":"2020","journal-title":"Anal. Chem."},{"issue":"2","key":"10.1016\/j.intimp.2024.113147_b0500","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1021\/acs.analchem.1c03338","article-title":"BoxCar and Library-Free Data-Independent Acquisition Substantially Improve the Depth, Range, and Completeness of Label-Free Quantitative Proteomics","volume":"94","author":"Mehta","year":"2022","journal-title":"Anal. Chem."},{"issue":"9","key":"10.1016\/j.intimp.2024.113147_b0505","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1016\/j.jprot.2010.05.011","article-title":"Implementation and evaluation of relative and absolute quantification in shotgun proteomics with label-free methods","volume":"73","author":"Grossmann","year":"2010","journal-title":"J. Proteomics"},{"issue":"38","key":"10.1016\/j.intimp.2024.113147_b0510","doi-asserted-by":"crossref","first-page":"13068","DOI":"10.1021\/acs.analchem.2c02255","article-title":"DirectMS1Quant: Ultrafast Quantitative Proteomics with MS\/MS-Free Mass Spectrometry","volume":"94","author":"Ivanov","year":"2022","journal-title":"Anal. Chem."},{"issue":"28","key":"10.1016\/j.intimp.2024.113147_b0515","doi-asserted-by":"crossref","first-page":"10595","DOI":"10.1021\/acs.analchem.3c00525","article-title":"TMT Labeling under Acidic pH Overcomes Detrimental Overlabeling and Improves Peptide Identification Rates","volume":"95","author":"Liao","year":"2023","journal-title":"Anal. Chem."},{"issue":"31","key":"10.1016\/j.intimp.2024.113147_b0520","doi-asserted-by":"crossref","first-page":"10893","DOI":"10.1021\/acs.analchem.2c01036","article-title":"Comparative Assessment of Quantification Methods for Tumor Tissue Phosphoproteomics","volume":"94","author":"Zhang","year":"2022","journal-title":"Anal. Chem."},{"issue":"5","key":"10.1016\/j.intimp.2024.113147_b0525","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1021\/acs.jproteome.8b00016","article-title":"Proteome-Wide Evaluation of Two Common Protein Quantification Methods","volume":"17","author":"O'Connell","year":"2018","journal-title":"J Proteome Res"},{"issue":"1","key":"10.1016\/j.intimp.2024.113147_b0530","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/s12276-023-00928-y","article-title":"SIRT5-related desuccinylation modification of AIFM1 protects against compression-induced intervertebral disc degeneration by regulating mitochondrial homeostasis","volume":"55","author":"Mao","year":"2023","journal-title":"Exp. Mol. Med."},{"issue":"6","key":"10.1016\/j.intimp.2024.113147_b0535","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1074\/mcp.TIR119.001720","article-title":"MaxQuant Software for Ion Mobility Enhanced Shotgun Proteomics","volume":"19","author":"Prianichnikov","year":"2020","journal-title":"Mol. Cell. Proteomics"},{"issue":"6","key":"10.1016\/j.intimp.2024.113147_b0540","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1002\/mas.21781","article-title":"Advances in data-independent acquisition mass spectrometry towards comprehensive digital proteome landscape","volume":"42","author":"Kitata","year":"2023","journal-title":"Mass Spectrom. Rev."},{"issue":"4","key":"10.1016\/j.intimp.2024.113147_b0545","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s13361-018-2122-8","article-title":"Improving Precursor Selectivity in Data-Independent Acquisition Using Overlapping Windows","volume":"30","author":"Amodei","year":"2019","journal-title":"J. Am. Soc. Mass Spectrom."},{"issue":"1","key":"10.1016\/j.intimp.2024.113147_b0550","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/nmeth.1408","article-title":"High-throughput generation of selected reaction-monitoring assays for proteins and proteomes","volume":"7","author":"Picotti","year":"2010","journal-title":"Nat. Methods"},{"key":"10.1016\/j.intimp.2024.113147_b0555","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jprot.2018.02.008","article-title":"Application of targeted mass spectrometry in bottom-up proteomics for systems biology research","volume":"189","author":"Manes","year":"2018","journal-title":"J. Proteomics"},{"issue":"10","key":"10.1016\/j.intimp.2024.113147_b0560","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nmeth1088","article-title":"Analysis and validation of proteomic data generated by tandem mass spectrometry","volume":"4","author":"Nesvizhskii","year":"2007","journal-title":"Nat. Methods"},{"issue":"12","key":"10.1016\/j.intimp.2024.113147_b0565","doi-asserted-by":"crossref","first-page":"4051","DOI":"10.1021\/acs.jproteome.8b00485","article-title":"Expanding the Use of Spectral Libraries in Proteomics","volume":"17","author":"Deutsch","year":"2018","journal-title":"J. Proteome Res."},{"issue":"5","key":"10.1016\/j.intimp.2024.113147_b0570","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1093\/bib\/bbx033","article-title":"Evaluating de novo sequencing in proteomics: already an accurate alternative to database-driven peptide identification?","volume":"19","author":"Muth","year":"2018","journal-title":"Brief. Bioinform."},{"issue":"6","key":"10.1016\/j.intimp.2024.113147_b0575","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1074\/mcp.M800535-MCP200","article-title":"Spectral profiles, a novel representation of tandem mass spectra and their applications for de novo peptide sequencing and identification","volume":"8","author":"Kim","year":"2009","journal-title":"Mol. Cell. Proteomics"},{"issue":"1","key":"10.1016\/j.intimp.2024.113147_b0580","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.chembiol.2015.11.006","article-title":"Chemical Methods for Encoding and Decoding of Posttranslational Modifications","volume":"23","author":"Chuh","year":"2016","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.intimp.2024.113147_b0585","doi-asserted-by":"crossref","unstructured":"Zhang, B. and M. Bassani-Sternberg, Current perspectives on mass spectrometry-based immunopeptidomics: the computational angle to tumor antigen discovery. J Immunother Cancer, 2023. 11(10).","DOI":"10.1136\/jitc-2023-007073"},{"issue":"11","key":"10.1016\/j.intimp.2024.113147_b0590","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1038\/nmeth.3144","article-title":"Proteogenomics: concepts, applications and computational strategies","volume":"11","author":"Nesvizhskii","year":"2014","journal-title":"Nat. Methods"},{"issue":"2","key":"10.1016\/j.intimp.2024.113147_b0595","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/s41587-021-01038-8","article-title":"Identification of tumor antigens with immunopeptidomics","volume":"40","author":"Chong","year":"2022","journal-title":"Nat. Biotechnol."},{"issue":"1","key":"10.1016\/j.intimp.2024.113147_b0600","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.smim.2015.11.002","article-title":"Cancer immunotherapy targeting neoantigens","volume":"28","author":"Lu","year":"2016","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.intimp.2024.113147_b0605","doi-asserted-by":"crossref","first-page":"10238","DOI":"10.1038\/ncomms10238","article-title":"Global proteogenomic analysis of human MHC class I-associated peptides derived from non-canonical reading frames","volume":"7","author":"Laumont","year":"2016","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.intimp.2024.113147_b0610","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.108815","article-title":"Most non-canonical proteins uniquely populate the proteome or immunopeptidome","volume":"34","author":"Ruiz Cuevas","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.intimp.2024.113147_b0615","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcpro.2021.100143","article-title":"Immunopeptidogenomics: Harnessing RNA-Seq to Illuminate the Dark Immunopeptidome","volume":"20","author":"Scull","year":"2021","journal-title":"Mol. Cell. Proteomics"},{"issue":"1","key":"10.1016\/j.intimp.2024.113147_b0620","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/s13059-023-03029-1","article-title":"BamQuery: a proteogenomic tool to explore the immunopeptidome and prioritize actionable tumor antigens","volume":"24","author":"Cuevas","year":"2023","journal-title":"Genome Biol."},{"issue":"9","key":"10.1016\/j.intimp.2024.113147_b0625","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1101\/gr.6427907","article-title":"Whole proteome analysis of post-translational modifications: applications of mass-spectrometry for proteogenomic annotation","volume":"17","author":"Gupta","year":"2007","journal-title":"Genome Res."},{"key":"10.1016\/j.intimp.2024.113147_b0630","doi-asserted-by":"crossref","unstructured":"Thind, A.S., et al., Demystifying emerging bulk RNA-Seq applications: the application and utility of bioinformatic methodology. Brief Bioinform, 2021. 22(6).","DOI":"10.1093\/bib\/bbab259"},{"issue":"1","key":"10.1016\/j.intimp.2024.113147_b0635","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s13045-021-01105-2","article-title":"Applications of single-cell sequencing in cancer research: progress and perspectives","volume":"14","author":"Lei","year":"2021","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.intimp.2024.113147_b0640","doi-asserted-by":"crossref","unstructured":"Creighton, C.J., Clinical proteomics towards multiomics in cancer. Mass Spectrom Rev, 2022: p. e21827.","DOI":"10.1002\/mas.21827"},{"issue":"8","key":"10.1016\/j.intimp.2024.113147_b0645","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-018-0071-8","article-title":"Single-cell RNA sequencing technologies and bioinformatics pipelines","volume":"50","author":"Hwang","year":"2018","journal-title":"Exp. Mol. Med."},{"issue":"11","key":"10.1016\/j.intimp.2024.113147_b0650","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/s41576-023-00652-3","article-title":"Transposable elements: McClintock's legacy revisited","volume":"24","author":"Feschotte","year":"2023","journal-title":"Nat. Rev. Genet."},{"issue":"4","key":"10.1016\/j.intimp.2024.113147_b0655","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/nrg2072","article-title":"Transposable elements and the epigenetic regulation of the genome","volume":"8","author":"Slotkin","year":"2007","journal-title":"Nat. Rev. Genet."},{"issue":"7","key":"10.1016\/j.intimp.2024.113147_b0660","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nrc.2017.35","article-title":"Transposable elements in cancer","volume":"17","author":"Burns","year":"2017","journal-title":"Nat. Rev. Cancer"},{"issue":"5","key":"10.1016\/j.intimp.2024.113147_b0665","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1007\/s00438-023-02033-1","article-title":"The transposable element-derived transcript of LIN28B has a placental origin and is not specific to tumours","volume":"298","author":"Lynch-Sutherland","year":"2023","journal-title":"Mol. Genet. Genomics"},{"issue":"10","key":"10.1016\/j.intimp.2024.113147_b0670","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110916","article-title":"Single-cell RNA-seq-based proteogenomics identifies glioblastoma-specific transposable elements encoding HLA-I-presented peptides","volume":"39","author":"Bont\u00e9","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.intimp.2024.113147_b0675","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.720886","article-title":"Metabolomics Analysis Reveals Interaction of Base-Line Chemotherapy and Shiyiwei Shenqi Tablets in Breast Cancer Treatment","volume":"12","author":"Wan","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"7","key":"10.1016\/j.intimp.2024.113147_b0680","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1038\/s41591-020-0900-x","article-title":"Geospatial immune variability illuminates differential evolution of lung adenocarcinoma","volume":"26","author":"AbdulJabbar","year":"2020","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.intimp.2024.113147_b0685","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1158\/1541-7786.MCR-20-0949","article-title":"Genomic Alterations during the In Situ to Invasive Ductal Breast Carcinoma Transition Shaped by the Immune System","volume":"19","author":"Trinh","year":"2021","journal-title":"Mol. Cancer Res."},{"issue":"1","key":"10.1016\/j.intimp.2024.113147_b0690","doi-asserted-by":"crossref","first-page":"5361","DOI":"10.1038\/s41467-018-07767-w","article-title":"Local mutational diversity drives intratumoral immune heterogeneity in non-small cell lung cancer","volume":"9","author":"Jia","year":"2018","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.intimp.2024.113147_b0695","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1038\/s43018-023-00548-5","article-title":"The immunopeptidome landscape associated with T cell infiltration, inflammation and immune editing in lung cancer","volume":"4","author":"Kraemer","year":"2023","journal-title":"Nat Cancer"},{"issue":"3","key":"10.1016\/j.intimp.2024.113147_b0700","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.cels.2016.02.015","article-title":"Plasma Proteome Profiling to Assess Human Health and Disease","volume":"2","author":"Geyer","year":"2016","journal-title":"Cell Syst."},{"issue":"4","key":"10.1016\/j.intimp.2024.113147_b0705","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1093\/bib\/bbz051","article-title":"A comprehensive review and performance evaluation of bioinformatics tools for HLA class I peptide-binding prediction","volume":"21","author":"Mei","year":"2020","journal-title":"Brief. Bioinform."},{"issue":"4","key":"10.1016\/j.intimp.2024.113147_b0710","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41571-020-00460-2","article-title":"Advances in the development of personalized neoantigen-based therapeutic cancer vaccines","volume":"18","author":"Blass","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"11","key":"10.1016\/j.intimp.2024.113147_b0715","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1038\/s41587-019-0280-2","article-title":"Predicting HLA class II antigen presentation through integrated deep learning","volume":"37","author":"Chen","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.intimp.2024.113147_b0720","doi-asserted-by":"crossref","unstructured":"Reynisson, B., et al., NetMHCpan-4.1 and NetMHCIIpan-4.0: improved predictions of MHC antigen presentation by concurrent motif deconvolution and integration of MS MHC eluted ligand data. Nucleic Acids Res, 2020. 48(W1): p. W449-w454.","DOI":"10.1093\/nar\/gkaa379"},{"key":"10.1016\/j.intimp.2024.113147_b0725","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.3389\/fimmu.2018.01369","article-title":"Predicting HLA CD4 Immunogenicity in Human Populations","volume":"9","author":"Dhanda","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2024.113147_b0730","doi-asserted-by":"crossref","unstructured":"Yang, Q., et al., HLAIImaster: a deep learning method with adaptive domain knowledge predicts HLA II neoepitope immunogenic responses. Brief Bioinform, 2024. 25(4).","DOI":"10.1093\/bib\/bbae302"},{"key":"10.1016\/j.intimp.2024.113147_b0735","doi-asserted-by":"crossref","unstructured":"Wang, G., et al., TLimmuno2: predicting MHC class II antigen immunogenicity through transfer learning. Brief Bioinform, 2023. 24(3).","DOI":"10.1093\/bib\/bbad116"},{"issue":"10","key":"10.1016\/j.intimp.2024.113147_b0740","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.ccell.2022.09.001","article-title":"Peroxynitrite in the tumor microenvironment changes the profile of antigens allowing escape from cancer immunotherapy","volume":"40","author":"Tcyganov","year":"2022","journal-title":"Cancer Cell"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924016680?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924016680?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T02:56:00Z","timestamp":1728010560000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576924016680"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":148,"alternative-id":["S1567576924016680"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2024.113147","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Proteogenomics offers a novel avenue in neoantigen identification for cancer immunotherapy","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2024.113147","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"113147"}}